NCT04344041 - COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | Biotech Hunter

Enrollment

260

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

January 14, 2021

Study Completion Date

January 14, 2021

Conditions

Coronavirus

Interventions

DRUG

cholecalciferol 200,000 IU

Patients receive a vitamin D supplementation of 400,000 IU in a single oral dose.

DRUG

cholecalciferol 50,000 IU

Patients receive a vitamin D supplementation of 50,000 IU in a single oral dose

Trial Locations (9)

CHU Angers, Angers

CHU Bordeaux, Bordeaux

CH Le Mans, Le Mans

CHU Limoges, Limoges

CHU Nantes, Nantes

CHU Nice, Nice

CHU Saint Etienne, Saint-Etienne

CH Saumur, Saumur

CHU Tours, Tours